ANOVA BRCA specific result package

Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 12:18:58 iorio@ebi.ac.uk

Drug Domain: GDSC1000_paper_set, Analysis Domain: BRCA specific


Individual drug analysis: 249


Drug details and screening numbers

Drug Name: XL-184
Drug ID: 249
Synonyms: Cabozantinib
Brand name: Cometriq
Target: VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, Tie2,AXL

Number of cell lines screened: 922
Screening concentration range(s): 0.02 to 5.12 uM


Statistically significant associations identified = 0


All-tests volcano plot